Healthcare provider profile · identity verified

Amy J Kaissar, MD

Internal Medicine · INDIANAPOLIS, IN · NPI 1780652172

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	964	265
Levothyroxine Sodium	Levothyroxine Sodium	635	152
Amlodipine Besylate	Amlodipine Besylate	478	133
Lisinopril	Lisinopril	273	75
Losartan Potassium	Losartan Potassium	237	69
Rosuvastatin Calcium	Rosuvastatin Calcium	235	68
Metoprolol Succinate	Metoprolol Succinate	218	65
Omeprazole	Omeprazole	215	69
Gabapentin	Gabapentin	207	59
Metformin Hcl Er	Metformin Hcl	173	50
Famotidine	Famotidine	166	60
Jardiance	Empagliflozin	157	38
Trazodone Hcl	Trazodone Hcl	147	48
Hydrochlorothiazide	Hydrochlorothiazide	146	44
Simvastatin	Simvastatin	142	40
Zolpidem Tartrate	Zolpidem Tartrate	141	34
Carvedilol	Carvedilol	134	38
Metformin Hcl	Metformin Hcl	123	35
Escitalopram Oxalate	Escitalopram Oxalate	121	31
Pantoprazole Sodium	Pantoprazole Sodium	121	42
Valsartan	Valsartan	120	31
Tramadol Hcl	Tramadol Hcl	118	29
Sertraline Hcl	Sertraline Hcl	113	37
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	111	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	107	33
Ozempic	Semaglutide	96	20
Synthroid	Levothyroxine Sodium	96	25
Montelukast Sodium	Montelukast Sodium	91	28
Fluticasone Propionate	Fluticasone Propionate	90	36
Mounjaro	Tirzepatide	88	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	87	26
Pravastatin Sodium	Pravastatin Sodium	86	28
Bupropion Xl	Bupropion Hcl	83	24
Duloxetine Hcl	Duloxetine Hcl	83	26
Tamsulosin Hcl	Tamsulosin Hcl	80	23
Spironolactone	Spironolactone	79	24
Potassium Chloride	Potassium Chloride	78	27
Allopurinol	Allopurinol	77	23
Raloxifene Hcl	Raloxifene Hcl	76	22
Glipizide Er	Glipizide	75	24
Albuterol Sulfate Hfa	Albuterol Sulfate	74	30
Alprazolam	Alprazolam	71	20
Furosemide	Furosemide	71	25
Alendronate Sodium	Alendronate Sodium	61	22
Celecoxib	Celecoxib	61	17
Eliquis	Apixaban	59	14
Atenolol	Atenolol	58	17
Ezetimibe	Ezetimibe	58	18
Meloxicam	Meloxicam	58	20
Clopidogrel	Clopidogrel Bisulfate	53	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	18
Fluoxetine Hcl	Fluoxetine Hcl	50	17
Irbesartan	Irbesartan	50	13
Citalopram Hbr	Citalopram Hydrobromide	49	14
Metoprolol Tartrate	Metoprolol Tartrate	49	15
Estradiol	Estradiol	48	13
Januvia	Sitagliptin Phosphate	47	suppressed
Tizanidine Hcl	Tizanidine Hcl	43	19
Naproxen	Naproxen	41	18
Ondansetron Odt	Ondansetron	41	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	11
Doxazosin Mesylate	Doxazosin Mesylate	38	12
Lorazepam	Lorazepam	34	11
Oxybutynin Chloride Er	Oxybutynin Chloride	34	13
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	24
Valacyclovir	Valacyclovir Hcl	33	11
Clonazepam	Clonazepam	32	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Rybelsus	Semaglutide	31	suppressed
Pregabalin	Pregabalin	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Linzess	Linaclotide	26	suppressed
Lovastatin	Lovastatin	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Finasteride	Finasteride	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Meclizine Hcl	Meclizine Hcl	19	12
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Lansoprazole	Lansoprazole	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	11
Cephalexin	Cephalexin	14	13
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Felodipine Er	Felodipine	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Ramipril	Ramipril	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Torsemide	Torsemide	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Nystatin	Nystatin	11	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error